Amneal Pharmaceuticals, Inc. (AMRX)
17.78
-0.13
(-0.73%)
USD |
NASDAQ |
Aug 24, 16:00
17.77
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Debt to Equity Ratio : 84.54 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.54 |
| March 31, 2026 | -59.38 |
| December 31, 2025 | -37.98 |
| September 30, 2025 | -24.54 |
| June 30, 2025 | -23.03 |
| March 31, 2025 | -19.59 |
| December 31, 2024 | -23.73 |
| September 30, 2024 | -28.31 |
| June 30, 2024 | -47.42 |
| March 31, 2024 | -43.09 |
| December 31, 2023 | 139.05 |
| September 30, 2023 | 8.477 |
| June 30, 2023 | 8.985 |
| March 31, 2023 | 9.691 |
| December 31, 2022 | 9.534 |
| September 30, 2022 | 9.606 |
| June 30, 2022 | 10.34 |
| March 31, 2022 | 7.328 |
| December 31, 2021 | 7.982 |
| September 30, 2021 | 8.227 |
| June 30, 2021 | 8.430 |
| March 31, 2021 | 9.040 |
| December 31, 2020 | 9.711 |
| September 30, 2020 | 9.837 |
| June 30, 2020 | 9.720 |
| Date | Value |
|---|---|
| March 31, 2020 | 10.30 |
| December 31, 2019 | 11.92 |
| September 30, 2019 | 12.72 |
| June 30, 2019 | 6.054 |
| March 31, 2019 | 5.912 |
| December 31, 2018 | 5.332 |
| September 30, 2018 | 5.737 |
| June 30, 2018 | 5.628 |
| March 31, 2018 | |
| December 31, 2017 | -3.849 |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 1.448 |
| December 31, 2016 | 1.332 |
| September 30, 2016 | 0.9184 |
| June 30, 2016 | 0.4055 |
| March 31, 2016 | 0.402 |
| December 31, 2015 | 0.3997 |
| September 30, 2015 | 0.5156 |
| June 30, 2015 | 0.5886 |
| March 31, 2015 | 0.4667 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Liquidia Corp. | 0.9374 |
| Eli Lilly & Co. | 1.621 |
| Indivior Pharmaceuticals, Inc. | -2.447 |
| Viatris, Inc. | 0.9555 |
| Pfizer Inc. | 0.7418 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.776B |
| Total Liabilities (Quarterly) | 3.659B |
| Shareholders Equity (Quarterly) | 33.02M |
| Current Ratio | 2.204 |
| Net Debt Paydown Yield | -0.77% |